Abstract
Regulatory T cells (Treg cells) are an immunosuppressive subset of helper T cells, which are crucial to maintaining immune homeostasis, self-tolerance, and feto-maternal tolerance. Fetal alloantigens are recognized by conventional T cells; however, Treg cells, directly and indirectly, suppress their cytotoxic activities against fetuses. Murine models show that paternal antigen-specific Treg cells (PA-Treg cells) expand at the feto-maternal interface during pregnancies and seminal plasma-priming is important to this process. In humans, extensive epidemiological data of preeclampsia suggest that insufficient PA-specific tolerance relates to its development, but some epidemiological studies suggest the relationship between PA-specific tolerance and miscarriages. Recent basic research studies imply the immunological differences between miscarriages and preeclampsia from the standpoint of PA-Treg cells, which support epidemiological evidence. In this section, we review the latest understanding of Treg cell-mediated tolerance and prospects of clinical applications of immunological therapies and preventions for miscarriages and preeclampsia.
Original language | English |
---|---|
Title of host publication | Reproductive Immunology |
Subtitle of host publication | Basic Concepts |
Publisher | Elsevier |
Pages | 115-127 |
Number of pages | 13 |
ISBN (Electronic) | 9780128185087 |
DOIs | |
State | Published - 2021/01/01 |
Keywords
- Alloantigen
- Effector treg cell
- Miscarriage
- Naturally occurring treg cell
- Peripherally induced treg cell
- Preeclampsia
- Regulatory T cell
ASJC Scopus subject areas
- General Medicine
- General Immunology and Microbiology